Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Abattis Bioceuticals Corp ATTBF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.


GREY:ATTBF - Post by User

Abattis Bioceuticals Corp
Bullboard Posts
User Avatar Image
(8)
•••
Post by smithgeeon Feb 06, 2017 11:17pm
302 Views
Post# 25808130

Abattis Bioceuticals suspended by CSE

Abattis Bioceuticals suspended by CSE

 

2017-02-06 15:30 ET - Cease Trade/Suspend Company

 

CSE bulletin 2017-0204

Abattis Bioceuticals Corp. is in default of Canadian Securities Exchange requirements. Effective immediately, Abattis Bioceuticals will be suspended pursuant to CSE Policy 3. The suspension is considered a regulatory halt as defined in National Instrument 23-101 trading rules. A cease trade order has been issued by the British Columbia Securities Commission and the Ontario Securities Commission.

 

Date:  effective immediately, Feb. 6, 2017

Symbol:  ATT

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities